Biosensor for quantifying a substrate

(19)

(11)

EP 2 267 439 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	27.05.2015 Bulletin 2015/22

(45)	Mention of the grant of the patent:
	18.03.2015 Bulletin 2015/12

(21)	Application number: 10180644.6

(22)	Date of filing: 14.11.2000

(51)

International Patent Classification (IPC):

G01N 27/327^(2006.01)
C12Q 1/00^(2006.01)

G01N 33/487^(2006.01)

(54)	Biosensor for quantifying a substrate Biosensor zur Quantifizierung eines Substrats Biocapteur pour la quantification d'un substrat

(84)	Designated Contracting States:
	DE FR GB IT

(30)

Priority:

15.11.1999 JP 32455199
12.04.2000 JP 2000111255
14.04.2000 JP 2000113754
25.04.2000 JP 2000124394
27.04.2000 JP 2000128249
28.04.2000 JP 2000130158

(43)	Date of publication of application:
	29.12.2010 Bulletin 2010/52

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	00974977.1 / 1152239

(73)	Proprietor: Panasonic Healthcare Holdings Co., Ltd.
	Tokyo 105-8433 (JP)

(72)	Inventors:
	Miyazaki, Shoji Osaka 540-6207 (JP) Tokunaga, Hiroyuki Osaka 540-6207 (JP) Fujiwara, Masaki Osaka 540-6207 (JP) Yamanishi, Eriko Osaka 540-6207 (JP) Tokuno, Yoshinobu Osaka 540-6207 (JP)

(74)	Representative: Pautex Schneider, Nicole Véronique et al
	Novagraaf International SA Chemin de l'Echo 3 1213 Onex 1213 Onex (CH)

(56)

References cited: :

EP-A- 0 471 986
JP-A- 3 075 552
US-A- 4 683 048

EP-A1- 0 732 406
JP-A- 9 189 675

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).